Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

AN 207

Known as: AN-207 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Specific receptors for luteinizing hormone-releasing hormone (LH-RH), somatostatin, bombesin, and other peptides are found on… Expand
Review
2005
Review
2005
Chemotherapy is one of the main modalities in the therapy of cancer. However, an improvement in the efficacy and a reduction in… Expand
Review
2005
Review
2005
Abstract Targeted chemotherapy is a modern approach aimed at increasing the efficacy of systemic chemotherapy and reducing its… Expand
2005
2005
We determined by immunohistochemistry the presence of LHRH receptors in surgical specimens of human non-Hodgkin's lymphomas (NHL… Expand
Review
2004
Review
2004
Work on cytotoxic analogs of luteinizing hormone-releasing hormone (LH-RH), somatostatin and bombesin, designed for targeting… Expand
2000
2000
A highly potent derivative of doxorubicin, 2-pyrrolinodoxorubicin (AN-201), was linked to [D-Lys6]luteinizing hormone-releasing… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Review
1999
Review
1999
In view of non-specific toxicity of most chemotherapeutic agents against normal cells, the development of targeted chemotherapy… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
1999
1999
OBJECTIVE The aim of the study was to investigate the effects of the cytotoxic analog of luteinizing hormone-releasing hormone AN… Expand
1999
1999
Receptors for luteinizing hormone–releasing hormone (LH‐RH) are found in about 50% of human breast carcinomas. A highly potent… Expand
Highly Cited
1996
Highly Cited
1996
Doxorubicin (DOX) and its daunosamine-modified derivative, 2-pyrrolino-DOX, which is 500-1000 times more active than DOX, were… Expand